Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis

Mohammad Reza Beyranvand; Hootan Manhoobi; Saeid Shahraz; Ali-Asghar Kolahi

doi:10.18502/jthc.v18i2.13316

Mohammad Reza Beyranvand Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hootan Manhoobi Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saeid Shahraz Tufts Medical Center, Boston, MA, United States.
Ali-Asghar Kolahi Social Determinants of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

DOI: https://doi.org/10.18502/jthc.v18i2.13316

Keywords: Myocardial infarction; ST-elevation myocardial infarction; Iran

Abstract

Background: Cardiovascular diseases, specifically acute myocardial infarction (AMI), are the leading cause of death worldwide. In this review, we explain the characteristics of AMI in Iran.

Methods: We searched PubMed, Google, and Google Scholar for articles containing myocardial infarction, STEMI, and MI⁺ Iran in English and Persian words.

Results: The age-standardized incidence rate of MI was 73.3 per 100 000. The mean±SD age of patients was 61.20±13.40 years. In-hospital mortality of patients with AMI in the IMIR was 12.1%. Concerning AMI complications reported in the IMIR, 5.8% of patients experienced ventricular tachycardia, and 2.5% experienced ventricular fibrillation. The 1-year mortality rate in the IPACE2 study was 4.3%.

Conclusion: Only a few national studies are available in Iran regarding patients with AMI. A federal surveillance program continuously monitoring and tracking coronary events is essential to improve the general population’s health.